Cryomass Technologies, Inc. financial data

Location
Denver, CO
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 08 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.53 % -90.1%
Debt-to-equity -113 % -112%
Return On Assets -822 % -131%
Operating Margin -15.8K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 237M shares +15%
Common Stock, Shares, Outstanding 237M shares +12.9%
Entity Public Float 23.7M USD -38%
Common Stock, Value, Issued 237K USD +12.9%
Weighted Average Number of Shares Outstanding, Basic 237M shares +14.2%
Weighted Average Number of Shares Outstanding, Diluted 237M shares +14.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 29.2K USD
Cost of Revenue 5K USD
Research and Development Expense 15.4K USD +870%
General and Administrative Expense 1.33M USD -77.2%
Operating Income (Loss) -4.62M USD +68.6%
Nonoperating Income (Expense) -236K USD -193%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.8M USD +41.5%
Net Income (Loss) Attributable to Parent -8.82M USD +41.3%
Earnings Per Share, Basic 0 USD/shares +57.1%
Earnings Per Share, Diluted 0 USD/shares +71.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 183K USD +1834%
Accounts Receivable, after Allowance for Credit Loss, Current 6.19K USD
Assets, Current 296K USD +33.4%
Property, Plant and Equipment, Net 788K USD +7.01%
Intangible Assets, Net (Excluding Goodwill) 96.9K USD -97.6%
Goodwill 0 USD
Assets 1.13M USD +5.35%
Contract with Customer, Liability, Current 887K USD
Liabilities, Current 7.24M USD +266%
Contract with Customer, Liability, Noncurrent 60K USD
Liabilities 10.6M USD +135%
Retained Earnings (Accumulated Deficit) -57.2M USD -18.2%
Stockholders' Equity Attributable to Parent -9.44M USD -176%
Liabilities and Equity 1.13M USD +5.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.3K USD +98.1%
Net Cash Provided by (Used in) Investing Activities -13.7K USD +97.8%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 237M shares +12.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.35M USD +37.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 183K USD +1834%
Deferred Tax Assets, Valuation Allowance 10M USD +50.1%
Deferred Tax Assets, Gross 10M USD +50.2%
Depreciation 13.1K USD 0%
Preferred Stock, Shares Authorized 100K shares 0%
Additional Paid in Capital 47.6M USD +6.18%
Amortization of Intangible Assets 68.4K USD -80.7%
Share-based Payment Arrangement, Expense 25K USD -82.6%
Interest Expense 494K USD +200%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%